Ferinject®: FAIR-HF study meets primary endpoints in patients with Iron Deficiency and Chronic Heart Failure
Vifor Pharma has reached an important milestone in its clinical development program: The FAIR-HF Study - a study assessi…
Vifor Pharma has reached an important milestone in its clinical development program: The FAIR-HF Study - a study assessi…
Over 3,000 representatives of the offshore wind, oil and gas industries, plus policy makers, business people and scienti…
The style has changed, but not the content: "Many German motorists see motoring not just as a comfortable and fast means…
NOXXON Pharma AG (NOXXON) announced today the successful initial dosing of healthy volunteers with Spiegelmer® NOX-E36 i…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), a life sciences product development company that identifies and a…
BMW is pleased to announce the 5 Series Gran Turismo, a car which combines an understated coupé-like silhouette to the l…
Unterschiedliche Formen eines Gens sind möglicherweise der Grund dafür, dass einige Patienten nach einer Herzoperation e…
To understand overall infectivity, virus progression and disease-onset it is important to perform a detailed examination…
BMW's new flagship model will launch in September and feature two world debuts. The BMW 760Li will be powered by an all…
The net profit of the Galenica Group reached CHF 189.4 million in 2008, an increase of 40.4% This was the thirteenth con…